Table: begin end state 1 46 non-cytoplasmic 47 70 transmembrane 71 81 cytoplasmic 82 105 transmembrane 106 116 non-cytoplasmic 117 148 transmembrane 149 158 cytoplasmic 159 180 transmembrane 181 198 non-cytoplasmic 199 223 transmembrane 224 253 cytoplasmic 254 275 transmembrane 276 282 non-cytoplasmic 283 301 transmembrane 302 307 cytoplasmic 308 327 transmembrane 328 332 non-cytoplasmic 333 353 transmembrane 354 359 cytoplasmic
Input: >SMa0217 FitnessBrowser__Smeli:SMa0217 MGARRRARPVPRSPTIECQTVTPVLAESAAPRSRTQRQSILKQIMGMPAGAIFLVFMTLQ IVCIAGALLYPDEFRYLSPQNLTILMKAIPVLGCLALGAGVLMIAGEFDLSIGSVYTFTA VLMASLVNAGLSAFIAAPIAILTGLLIGSLNGHITLRFGLPSFIVTLGGLLFWRGAVLLY NGAVQVRFDPEPVFTSLFSGTLFGVNAAFIWIVLFVTGFHLLLHRHRFGNHVFATGGNRG AAEAIGINTSRVKLIAFAIAGGMAAVAGILATARVGSVQPGQGAGLELQAIAACVIGGLS LRGGRGSIIGIFLGVLLIHTITDVLLLLRAPGFYLDMFIATLIVLAAIFNHLIERRGLA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server